Sitagliptin Phosphate
CAS 654671-77-9 2 FDA-DMF suppliersSmall Molecule
Overview
Sitagliptin Phosphate is an orally active inhibitor of the DPP-4 enzyme, which is involved in glucose metabolism, and is used in the treatment of type 2 diabetes mellitus. It helps to increase insulin production and decrease the amount of sugar made by the body.
Therapeutic areas
EndocrinologyMetabolic DiseasesDiabetology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.